Teva Pharmaceutical reported 2.16B in Cash and Equivalent for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aspen Pharmacare APN:SJ 8.55B 1.25B
Jiangsu Hengrui Me. 600276:CH CH 14.33B 1.9B
Richter Gedeon RICHT:HB 59.86B 611M
Teva Pharmaceutical TEVA:IT 2.16B 120M